Q One of Your Major Research Focuses Is Angiogenesis Treatment. What Led You to Initially Work in This Area? When I was finishing my MD PhD and I was thinking about what I would do after Yale ...

Central to this resistance is angiogenesis—the abnormal formation of blood vessels within tumors. These newly formed vessels exacerbate tumor hypoxia and obstruct the delivery of therapeutic ...

It is quite conceivable that these integrins could play both positive and negative roles in different phases of angiogenesis and/or could act as balancers or integrators of positive and negative ...

Martin Friedlander, MD, PhD, discusses phase 3 macular telangiectasia findings, highlighting the potential for a decade-long ...

"The in vitro model demonstrates the cell-to-cell interactions leading to ASPS angiogenesis, which confirms previous in vivo ...

Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company advancing a new class of nanomedicine therapeutics that traverse tissue barriers to selectively target and reprogram activated cells in ...